Galectin Therapeutics Statistics

Total Valuation

GALT has a market cap or net worth of $231.96 million. The enterprise value is $332.96 million.

Market Cap	231.96M
Enterprise Value	332.96M

Important Dates

The next estimated earnings date is Tuesday, August 26, 2025, before market open.

Earnings Date	Aug 26, 2025
Ex-Dividend Date	n/a

Share Statistics

GALT has 63.29 million shares outstanding. The number of shares has increased by 3.02% in one year.

Current Share Class	63.29M
Shares Outstanding	63.29M
Shares Change (YoY)	+3.02%
Shares Change (QoQ)	+0.73%
Owned by Insiders (%)	20.88%
Owned by Institutions (%)	15.35%
Float	44.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.08

Current Ratio	0.08
Quick Ratio	0.07
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.53

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-143.58%
Return on Invested Capital (ROIC)	-536.87%
Return on Capital Employed (ROCE)	40.16%
Revenue Per Employee	n/a
Profits Per Employee	-$3.02M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +73.70% in the last 52 weeks. The beta is 0.83, so GALT's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	+73.70%
50-Day Moving Average	2.60
200-Day Moving Average	1.90
Relative Strength Index (RSI)	62.87
Average Volume (20 Days)	315,710

Short Selling Information

The latest short interest is 7.71 million, so 12.18% of the outstanding shares have been sold short.

Short Interest	7.71M
Short Previous Month	7.70M
Short % of Shares Out	12.18%
Short % of Float	17.46%
Short Ratio (days to cover)	22.30

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-40.68M
Pretax Income	-44.65M
Net Income	-45.31M
EBITDA	n/a
EBIT	-40.68M
Earnings Per Share (EPS)	-$0.72

Full Income Statement

Balance Sheet

The company has $7.43 million in cash and $108.43 million in debt, giving a net cash position of -$101.00 million or -$1.60 per share.

Cash & Cash Equivalents	7.43M
Total Debt	108.43M
Net Cash	-101.00M
Net Cash Per Share	-$1.60
Equity (Book Value)	-112.26M
Book Value Per Share	-1.81
Working Capital	-101.56M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-37.35M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GALT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.02%
Shareholder Yield	-3.02%
Earnings Yield	-19.53%
FCF Yield	n/a

Analyst Forecast

The average price target for GALT is $6.00, which is 63.71% higher than the current price. The consensus rating is "Buy".

Price Target	$6.00
Price Target Difference	63.71%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 23, 2012. It was a reverse split with a ratio of 1:6.

Last Split Date	Mar 23, 2012
Split Type	Reverse
Split Ratio	1:6

Scores

Altman Z-Score	n/a
Piotroski F-Score	2